Catheter Cardiovasc Interv
Dr. Alexander Bershadskiy, MD
- Medicare services, 2024
- 1,899
- Medicare patients, 2024
- 405
- Part D claims, 2024
- 1,504
- Publications
- 12
- Clinical trials
- 7
- Practice address
- 475 Seaview Ave, Staten Island, NY 10305
- Practice phone
- Call (718) 226-4502
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Staten Island University Hospital - North Campus
Staten Island, New York
Find Dr. Bershadskiy's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Alexander Bershadskiy is a hematologist and oncologist in Staten Island, New York
Dr. Bershadskiy practices at Staten Island University Hospital - North Campus in Staten Island, New York.
Dr. Bershadskiy's NPI, 1407016116, was assigned on June 16, 2008. Dr. Bershadskiy holds New York license 263136.
- NPI
- 1407016116NPI Registry (opens in a new tab)
- Medicare PAC ID
- 5395061303
- NPI enumeration date
- June 16, 2008
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (718) 226-4502
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 44
- Medical school graduation
- 2008
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Alexander Bershadskiy practices at Staten Island University Hospital - North Campus in Staten Island, New York
Dr. Bershadskiy's primary practice is Staten Island University Hospital - North Campus, at 475 Seaview Ave, Staten Island, NY 10305 in Richmond County. The practice phone is (718) 226-4502.
- Staten Island University Hospital - North Campus475 Seaview Ave, Staten Island, NY 10305 · Richmond CountyPhone(718) 226-4502
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Alexander Bershadskiy is affiliated with 2 sites of care and 3 medical groups
Dr. Bershadskiy's primary practice is Staten Island University Hospital - North Campus in Staten Island, New York. Dr. Bershadskiy is also affiliated with Staten Island University Hospital. The medical group on file is Northwell Health Physician Partners Cardiology at Great Neck. Dmand AI also links Dr. Bershadskiy to 2 more medical groups, each named with a free account.
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Alexander Bershadskiy's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bershadskiy practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Staten Island University Hospital - North Campus | Available with a free account |
| +1 more site and 2 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Alexander Bershadskiy is one of 996 hematologists and oncologists in New York
Hematology and oncology is Dr. Bershadskiy's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Bershadskiy is licensed in New York.
Specialties and state licenses
- Hematology and oncology, New YorkPrimary
Hematologists and oncologists near Dr. Bershadskiy
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Alexander Bershadskiy billed Medicare for 1,899 services in 2024
CMS data shows 1,899 Medicare services from Dr. Bershadskiy across 10 procedure codes in 2024, for 405 Medicare patients. Medicare paid $110,619 for them. Every service was in a facility, such as a hospital, rather than an office.
Dr. Bershadskiy's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 9162024: 1,18429%
- Other services
- 2023: 02024: 715
Dr. Bershadskiy compared with the New York median for hematologists and oncologists, 2024
- Dr. Bershadskiy
- New York median
- Medicare services
- 1,899vs 6682.8 times
- Medicare patients
- 405vs 21093% above
- Part D claims
- 1,079vs 2584.2 times
Medians across 940 hematologists and oncologists in New York with Dmand AI profiles that report each measure.
Dr. Bershadskiy's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Bershadskiy?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Bershadskiy and other hematologists and oncologists in New York.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Alexander Bershadskiy treated 405 Medicare patients in 2024, average age 75
CMS counts 405 Medicare patients who saw Dr. Bershadskiy in 2024. The largest group is 75 to 84, with 178 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 29% are also on Medicaid. Their average risk score is 2.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Bershadskiy's median patient age at 75, with 47% women.
Dr. Bershadskiy's Medicare patients by age, 2024
Dr. Bershadskiy's Medicare patients by sex, 2024
- Women19047%
- Men21553%
Chronic conditions among Dr. Bershadskiy's Medicare patients, 2024
- High blood pressure75%
- High cholesterol75%
- Arthritis57%
- Diabetes55%
- Ischemic heart disease55%
- Cancer52%
- Chronic kidney disease37%
- Heart failure34%
Share of Medicare patients with each condition. A patient can have several.
Dr. Bershadskiy's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 75
Patient panel by sex, all payers
- Women47%
- Men50%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Alexander Bershadskiy wrote 1,504 Medicare Part D claims in 2024
In 2024, Dr. Bershadskiy wrote 1,504 Medicare Part D claims for 209 patients. 66% of them were for generic drugs. CMS names the drug for 1,079 of them, across 34 drugs with 11 or more claims each, at $3,531,216 in total drug cost. In 2023, CMS named 977 claims across 35 drugs.
Dr. Bershadskiy's Part D claims by kind of drug, 2024
- Generic989 claims66%
- Brand-name and other515 claims34%
Dr. Bershadskiy's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Bershadskiy's Part D claims, 2024
- Opioids5%82 of 1,504 claims
- Antibiotics2%32 of 1,504 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 9772024: 1,07910%
Drugs named by CMS: 34 in 2024, 35 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Alexander Bershadskiy scored 79 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Bershadskiy for performance year 2024, reported as part of a group. Dr. Bershadskiy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bershadskiy as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Bershadskiy's MIPS scores, performance year 2024
- 79of 100Final score
- 57.9of 100Quality
- 77of 100Promoting Interoperability
- 40of 100Improvement Activities
- 80of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Alexander Bershadskiy has 12 publications on record
Dmand AI links 12 papers to Dr. Bershadskiy, published from 2012 to 2024. 2021 was the busiest year, with 2. Dr. Bershadskiy has published most often in Cureus. Dr. Bershadskiy's most frequent co-authors are Kira MacDougall, MD, Mohammad Abureesh, MD and Laurence Aoun.
Dr. Bershadskiy's papers by year, 2012 to 2024
Dr. Bershadskiy's most frequent co-authors
- Kira MacDougall, MD2 shared papers
- Mohammad Abureesh, MD1 shared paper
- Laurence Aoun1 shared paper
Recent publications by Dr. Bershadskiy
Oncology (Williston Park)
See who Dr. Bershadskiy researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Bershadskiy works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Alexander Bershadskiy has worked on 7 clinical trials
Dmand AI links Dr. Bershadskiy to 7 clinical trials, 4 of them phase 3 studies. 5 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Carcinoma, Bronchogenic and Rectal Neoplasms. National Cancer Institute (NCI) sponsors the most, 5.
Clinical trials with Dr. Bershadskiy by phase
- NonePhase 1: no trials
- 2Phase 2: 2 trials
- 4Phase 3: 4 trials
- NonePhase 4: no trials
Conditions in Dr. Bershadskiy's trials
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Bronchogenic
- Rectal Neoplasms
- Rectal Diseases
Investigators on the most trials with Dr. Bershadskiy
- Maria I. Quejada, MD5 shared trials
- Sheetal Sumat Acharya, MD4 shared trials
- Joseph Aisner4 shared trials
Recent clinical trials with Dr. Bershadskiy
Vitamin D3 with Chemotherapy and Bevacizumab in Treating Patients with Advanced or Metastatic Colorectal Cancer (opens in a new tab)
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer (opens in a new tab)
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial) (opens in a new tab)
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial) (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Alexander Bershadskiy received $104 in industry payments from 2016 to 2022
CMS Open Payments shows 7 general payments to Dr. Bershadskiy from 5 drug and device companies from 2016 to 2022. Food and beverage make up the largest share, 89% of the total. Bayer HealthCare Pharmaceuticals Inc. paid the most, $29.
General payments to Dr. Bershadskiy by program year, 2016 to 2022
General payments to Dr. Bershadskiy by kind, 2016 to 2022
- Food and beverage$9289%
- Education$1211%
Companies that paid Dr. Bershadskiy the most, 2016 to 2022
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Alexander Bershadskiy's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Alexander Bershadskiy
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Alexander Bershadskiy's NPI number?
Dr. Alexander Bershadskiy's NPI number is 1407016116. It was assigned on June 16, 2008, and it is active in the NPI Registry.
What kind of doctor is Dr. Alexander Bershadskiy?
Dr. Alexander Bershadskiy is a hematologist and oncologist in Staten Island, New York. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Alexander Bershadskiy practice?
Dr. Bershadskiy practices at 475 Seaview Ave, Staten Island, NY 10305. Dr. Bershadskiy's primary practice is Staten Island University Hospital - North Campus in Staten Island, New York. Dmand AI also links Dr. Bershadskiy to 2 medical groups.
What is Dr. Alexander Bershadskiy's office phone number?
The practice phone on file for Dr. Bershadskiy is (718) 226-4502.
What is Dr. Alexander Bershadskiy's medical license number?
Dr. Bershadskiy holds New York license 263136.
Which hospitals is Dr. Alexander Bershadskiy affiliated with?
Dr. Bershadskiy is affiliated with Staten Island University Hospital.
What medical group is Dr. Alexander Bershadskiy part of?
Dr. Bershadskiy is linked to Northwell Health Physician Partners Cardiology at Great Neck. Dmand AI links Dr. Bershadskiy to 2 more medical groups.
Does Dr. Alexander Bershadskiy accept Medicare?
Yes. CMS data shows Dr. Bershadskiy billed Medicare for 1,899 services in 2024, and Dr. Bershadskiy accepts Medicare assignment.
Does Dr. Alexander Bershadskiy offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Bershadskiy as offering telehealth services.
What is Dr. Alexander Bershadskiy's MIPS score?
Dr. Bershadskiy's MIPS final score for performance year 2024 is 79 out of 100, reported as part of a group.
Show 7 more questionsShow fewer questions
How many Medicare patients does Dr. Alexander Bershadskiy see?
CMS counts 405 Medicare patients who saw Dr. Bershadskiy in 2024, with an average age of 75.
What services does Dr. Alexander Bershadskiy bill to Medicare?
In 2024, Dr. Bershadskiy's most billed Medicare services were medicare service (G2211), office visit, established patient (99214) and hospital inpatient care (99232).
What drugs does Dr. Alexander Bershadskiy prescribe most?
In 2024 Medicare Part D data, Dr. Bershadskiy's most prescribed drugs by claims were Abiraterone Acetate, Prednisone and Ondansetron HCl.
Has Dr. Alexander Bershadskiy received payments from drug or device companies?
CMS Open Payments shows $104 in general payments to Dr. Bershadskiy from 5 companies from 2016 to 2022. The largest total came from Bayer HealthCare Pharmaceuticals Inc.
How long has Dr. Alexander Bershadskiy been practicing?
Dr. Bershadskiy graduated from medical school in 2008, 18 years ago.
Does Dr. Alexander Bershadskiy do research?
Dmand AI links 12 publications to Dr. Bershadskiy, published from 2012 to 2024. Dr. Bershadskiy has worked on 7 clinical trials.
Who does Dr. Alexander Bershadskiy publish with?
Dr. Bershadskiy's most frequent co-authors are Kira MacDougall, MD (2 shared papers), Mohammad Abureesh, MD (1 shared paper) and Laurence Aoun (1 shared paper).
Selling to hematology and oncology practices?
See hematologists and oncologists in New York by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card